GILDCL / Gilead Sciences, Inc. (SNSE) - Forecast, Price Target, Estimates, Predictions

Gilead Sciences, Inc.
CL ˙ SNSE ˙ US3755581036
Projected Stock Price
No data available.
Projected Revenue

No data available.
Projected Earnings Per Share

2.25 ↑43.19%

Estimated quarterly earnings by December 31, 2026.

Price Target

Update Frequency: Monthly

Record Date Projection Date High Low Median Average
2025-03-04 2026-03-04 129,263.63 78,429.40 104,320.01 103,983.86
Stock Upgrades/Downgrades

This card shows analyst upgrades/downgrades for Gilead Sciences, Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.

The standard analyst ratings are generally as follows:
  • Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
  • Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
  • Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.

When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.

The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.

Why Are Analyst Ratings important?

In addition to being able to interpret financial data, stock analysts have connections within the companies they cover that give them access to information retail investors do not have.

Therefore, analyst ratings can help you find opportunities in the market. However, they are guidelines more than recommendations. This is why it’s important to look at analyst ratings over a period of time.

If analysts change their ratings frequently, you should pay close attention to the company’s fundamentals. For example, has there been a significant change to the company’s earnings growth and/or debt?

You should also pay attention to the number of analysts covering a stock over the course of a year. In general, the more analysts who cover the stock give the consensus rating more credibility, but each individual rating less overall weight.

How to Use Analyst Ratings ?

Analyst ratings are one data point for you to consider. Here are some strategies you can use to fine tune your research.

Look at more than one analyst and don’t hesitate to look at analysts that have differing views. This can help challenge any preconceived ideas you have about a stock and point out ways in which your thesis for owning or avoiding a stock may have changed.

Compare a stock’s rating with other stocks in its industry or sector. In some cases, a stock is simply superior to others in its sector. However, at other times, it could be overvalued based on investor sentiment instead of fundamentals.

How are the Fintel Analyst Ratings different?

Analyst ratings by Fintel are presented in close to real-time to stay ahead of generalized information flow. Combined with target price estimates and revenue estimates for the company you have greater accuracy despite market volatility.

Date Analyst Prior Latest
Recommendation
Action
2025-02-12 Wells Fargo Overweight Overweight Maintains
2025-02-12 BMO Capital Outperform Outperform Maintains
2025-02-12 Goldman Sachs Neutral Neutral Maintains
2025-02-12 RBC Capital Sector Perform Sector Perform Maintains
2024-09-09 Cantor Fitzgerald Neutral Neutral Reiterate
2024-11-21 Mizuho Outperform Outperform Maintains
2025-03-04 Oppenheimer Outperform Outperform Maintains
2024-11-21 UBS Neutral Neutral Maintains
2024-08-15 Truist Securities Hold Hold Maintains
2024-08-15 Needham Hold Reiterate
2024-11-07 Piper Sandler Overweight Overweight Maintains
2024-11-07 Barclays Equal-Weight Equal-Weight Maintains
2024-11-07 Wells Fargo Overweight Overweight Maintains
2024-11-07 Cantor Fitzgerald Neutral Neutral Maintains
2024-11-07 Goldman Sachs Neutral Neutral Maintains
2024-11-07 RBC Capital Sector Perform Sector Perform Maintains
2024-11-07 JP Morgan Overweight Overweight Maintains
2024-11-07 Baird Neutral Neutral Maintains
2024-11-07 BMO Capital Outperform Outperform Maintains
2024-11-07 Oppenheimer Outperform Outperform Maintains
2024-11-07 Needham Hold Reiterate
2025-01-10 Morgan Stanley Equal-Weight Overweight Upgrade
2024-10-21 Leerink Partners Market Perform Outperform Upgrade
2024-09-16 Cantor Fitzgerald Neutral Neutral Reiterate
2024-10-07 Barclays Equal-Weight Equal-Weight Maintains
2024-10-07 Wells Fargo Equal-Weight Overweight Upgrade
2024-10-17 BMO Capital Outperform Outperform Maintains
2024-10-17 Bernstein Outperform Initiate
2024-11-14 Citigroup Buy Initiate
2025-02-03 RBC Capital Sector Perform Sector Perform Reiterate
2024-11-15 Wolfe Research Outperform Initiate
2024-11-08 Truist Securities Hold Hold Maintains
2024-11-08 Maxim Group Buy Hold Downgrade
2024-10-29 RBC Capital Sector Perform Sector Perform Reiterate
2024-08-09 Cantor Fitzgerald Neutral Neutral Reiterate
2024-08-09 RBC Capital Sector Perform Sector Perform Maintains
2024-08-09 BMO Capital Outperform Outperform Maintains
2023-01-03 RBC Capital Outperform Sector Perform Downgrade
2022-12-13 B of A Securities Neutral Reiterate
2022-12-01 Morgan Stanley Equal-Weight Maintains
2022-11-08 Cowen & Co. Outperform Maintains
2022-11-08 Mizuho Buy Maintains
2022-11-01 SVB Leerink Market Perform Maintains
2022-10-31 Maxim Group Buy Maintains
2022-10-31 Barclays Underweight Equal-Weight Upgrade
2022-10-28 Morgan Stanley Equal-Weight Maintains
2022-10-28 RBC Capital Outperform Maintains
2022-10-28 Wells Fargo Equal-Weight Maintains
2022-10-28 Piper Sandler Neutral Overweight Upgrade
2022-10-28 Truist Securities Hold Buy Upgrade
2022-10-13 Morgan Stanley Equal-Weight Maintains
2022-10-12 Barclays Underweight Maintains
2022-10-04 JP Morgan Neutral Overweight Upgrade
2022-09-15 Truist Securities Hold Maintains
2022-09-13 Wells Fargo Equal-Weight Maintains
2022-07-26 Piper Sandler Neutral Maintains
2022-07-15 Morgan Stanley Equal-Weight Maintains
2022-07-13 Cantor Fitzgerald Neutral Initiate
2022-05-23 SVB Leerink Market Perform Initiate
2022-05-17 Piper Sandler Neutral Maintains
2022-04-29 BMO Capital Market Perform Maintains
2022-04-29 Piper Sandler Neutral Maintains
2022-04-12 Morgan Stanley Equal-Weight Maintains
2022-04-12 RBC Capital Outperform Maintains
2022-04-04 Piper Sandler Neutral Maintains
2022-03-22 Wells Fargo Equal-Weight Maintains
2022-03-10 Barclays Underweight Maintains
2022-03-08 RBC Capital Outperform Maintains
2022-02-28 BMO Capital Outperform Market Perform Downgrade
2022-02-08 Mizuho Buy Maintains
2022-02-02 Morgan Stanley Equal-Weight Maintains
2022-01-28 Argus Research Hold Buy Upgrade
2022-01-18 Morgan Stanley Equal-Weight Maintains
2022-01-06 Morgan Stanley Overweight Equal-Weight Downgrade
2021-12-09 Wells Fargo Equal-Weight Initiate
2021-12-06 Goldman Sachs Neutral Initiate
2021-10-29 SVB Leerink Outperform Maintains
2021-10-12 Morgan Stanley Overweight Maintains
2021-07-30 RBC Capital Outperform Maintains
2021-07-30 SVB Leerink Outperform Maintains
2021-04-30 SVB Leerink Outperform Maintains
2021-04-30 Morgan Stanley Overweight Maintains
2021-04-19 Morgan Stanley Overweight Maintains
2021-04-01 Bernstein Market Perform Outperform Upgrade
2021-03-30 Redburn Neutral Buy Upgrade
2021-02-11 SVB Leerink Outperform Maintains
2021-02-05 Credit Suisse Neutral Maintains
2021-02-05 SVB Leerink Outperform Maintains
2021-02-05 Morgan Stanley Overweight Maintains
2021-01-19 Morgan Stanley Equal-Weight Overweight Upgrade
2024-07-22 Cantor Fitzgerald Neutral Neutral Maintains
2024-07-08 Raymond James Market Perform Outperform Upgrade
2024-04-26 RBC Capital Sector Perform Sector Perform Maintains
2024-04-26 Morgan Stanley Equal-Weight Equal-Weight Maintains
2024-04-26 TD Cowen Buy Buy Maintains
2024-04-26 Needham Hold Reiterate
2024-04-24 HSBC Reduce Hold Upgrade
2024-04-19 Oppenheimer Outperform Outperform Maintains
2024-04-17 UBS Neutral Neutral Maintains
2024-03-04 Wells Fargo Equal-Weight Equal-Weight Maintains
2024-02-22 Mizuho Buy Buy Maintains
2024-02-22 Truist Securities Buy Hold Downgrade
2024-02-14 RBC Capital Sector Perform Sector Perform Maintains
2024-02-12 Barclays Equal-Weight Equal-Weight Maintains
2024-02-12 Oppenheimer Outperform Outperform Maintains
2024-02-07 Wells Fargo Equal-Weight Equal-Weight Maintains
2024-02-07 RBC Capital Sector Perform Sector Perform Maintains
2024-02-07 Cantor Fitzgerald Neutral Neutral Maintains
2024-01-23 Barclays Equal-Weight Equal-Weight Maintains
2023-11-14 RBC Capital Sector Perform Sector Perform Maintains
2023-11-09 Deutsche Bank Hold Initiate
2023-09-08 B of A Securities Neutral Buy Upgrade
2023-09-06 Truist Securities Buy Buy Reiterate
2023-09-06 HSBC Reduce Initiate
2023-08-04 RBC Capital Sector Perform Sector Perform Maintains
2023-08-04 Morgan Stanley Equal-Weight Equal-Weight Maintains
2023-07-24 Piper Sandler Overweight Overweight Maintains
2023-07-24 Cantor Fitzgerald Neutral Neutral Reiterate
2023-07-24 Barclays Equal-Weight Equal-Weight Maintains
2023-07-20 Cantor Fitzgerald Neutral Neutral Maintains
2023-07-11 Morgan Stanley Equal-Weight Equal-Weight Reiterate
2023-07-11 Barclays Equal-Weight Equal-Weight Maintains
2023-06-23 RBC Capital Sector Perform Sector Perform Reiterate
2023-05-16 BMO Capital Market Perform Outperform Upgrade
2023-05-01 Morgan Stanley Equal-Weight Maintains
2023-04-28 RBC Capital Sector Perform Maintains
2023-04-25 RBC Capital Sector Perform Reiterate
2023-04-12 Morgan Stanley Equal-Weight Maintains
2023-03-06 RBC Capital Sector Perform Maintains
2023-02-14 Mizuho Buy Maintains
2023-02-03 SVB Leerink Market Perform Maintains
2023-02-03 Morgan Stanley Equal-Weight Maintains
2023-02-03 Piper Sandler Overweight Maintains
2023-01-24 Morgan Stanley Equal-Weight Maintains
2023-01-19 Piper Sandler Overweight Maintains
2023-01-18 Barclays Equal-Weight Maintains
2023-01-03 Wells Fargo Equal-Weight Maintains
2016-04-29 Maxim Group Buy Hold Downgrade
2016-04-29 Citigroup Buy Maintains
2016-04-26 Credit Suisse Outperform Maintains
2024-07-01 RBC Capital Sector Perform Sector Perform Reiterate
2024-06-20 Baird Neutral Neutral Maintains
2024-06-14 RBC Capital Sector Perform Sector Perform Reiterate
2024-04-29 Barclays Equal-Weight Equal-Weight Maintains
2020-12-16 Credit Suisse Neutral Maintains
2020-11-24 Truist Securities Buy Initiate
2020-11-06 Wells Fargo Overweight Equal-Weight Downgrade
2020-11-03 Morgan Stanley Equal-Weight Reiterate
2020-10-29 BMO Capital Market Perform Maintains
2020-10-29 Cantor Fitzgerald Overweight Reiterate
2020-10-29 Piper Sandler Overweight Maintains
2020-10-29 Wells Fargo Equal-Weight Maintains
2020-10-29 SVB Leerink Outperform Maintains
2020-10-28 UBS Neutral Initiate
2020-09-18 RBC Capital Outperform Maintains
2020-09-15 Maxim Group Hold Buy Upgrade
2020-09-15 RBC Capital Outperform Maintains
2020-09-14 SVB Leerink Outperform Maintains
2020-09-10 Oppenheimer Outperform Maintains
2020-08-20 Truist Securities Hold Maintains
2020-08-19 Piper Sandler Overweight Maintains
2020-08-19 Cantor Fitzgerald Overweight Maintains
2020-07-31 Morgan Stanley Equal-Weight Maintains
2020-07-31 Credit Suisse Neutral Maintains
2020-07-20 Credit Suisse Underperform Neutral Upgrade
2020-07-15 Morgan Stanley Equal-Weight Maintains
2020-05-26 SunTrust Robinson Humphrey Sell Hold Upgrade
2020-05-21 Cowen & Co. Outperform Initiate
2020-05-01 Morgan Stanley Equal-Weight Maintains
2020-05-01 Oppenheimer Outperform Maintains
2020-05-01 SVB Leerink Market Perform Maintains
2020-05-01 Raymond James Outperform Market Perform Downgrade
2020-05-01 SunTrust Robinson Humphrey Hold Sell Downgrade
2020-05-01 JP Morgan Overweight Neutral Downgrade
2020-04-29 CFRA Sell Maintains
2020-04-27 UBS Buy Neutral Downgrade
2020-04-20 BMO Capital Outperform Market Perform Downgrade
2020-04-20 Wells Fargo Overweight Equal-Weight Downgrade
2020-04-17 Baird Neutral Outperform Upgrade
2020-04-17 CFRA Hold Sell Downgrade
2020-04-07 Cantor Fitzgerald Overweight Reiterate
2020-03-20 Piper Sandler Neutral Overweight Upgrade
2020-03-19 Wells Fargo Overweight Maintains
2020-03-18 DZ Bank Hold Buy Upgrade
2020-03-09 RBC Capital Top Pick Outperform Downgrade
2020-02-28 DZ Bank Buy Hold Downgrade
2020-02-27 Barclays Underweight Initiate
2020-02-06 Bernstein Outperform Market Perform Downgrade
2020-02-05 Credit Suisse Underperform Maintains
2020-02-05 Raymond James Strong Buy Outperform Downgrade
2020-02-05 B of A Securities Neutral Maintains
2020-01-21 Guggenheim Securities Buy Neutral Downgrade
2019-12-20 Wells Fargo Overweight Maintains
2019-12-13 Credit Suisse Neutral Underperform Downgrade
2019-11-12 SunTrust Robinson Humphrey Hold Initiate
2019-11-05 Wells Fargo Outperform Maintains
2019-10-25 Oppenheimer Outperform Maintains
2019-10-25 Maxim Group Buy Hold Downgrade
2019-10-25 BMO Capital Outperform Maintains
2019-10-25 Raymond James Strong Buy Maintains
2019-08-19 Wells Fargo Outperform Initiate
2019-07-31 Credit Suisse Neutral Maintains
2019-07-31 Raymond James Strong Buy Maintains
2019-07-29 RBC Capital Outperform Top Pick Upgrade
2019-07-15 Wells Fargo Market Perform Outperform Upgrade
2019-05-28 Goldman Sachs Neutral Sell Downgrade
2019-05-23 Citigroup Neutral Buy Upgrade
2019-05-21 Credit Suisse Neutral Initiate
2019-04-26 Bernstein Outperform Initiate
2019-04-17 Longbow Research Buy Neutral Downgrade
2019-04-10 UBS Neutral Buy Upgrade
2019-03-15 BMO Capital Outperform Initiate
2019-02-12 Raymond James Strong Buy Strong Buy Maintains
2019-02-12 Citigroup Buy Neutral Downgrade
2019-02-12 Wells Fargo Outperform Market Perform Downgrade
2019-01-03 Oppenheimer Perform Outperform Upgrade
2018-12-19 Morgan Stanley Equal-Weight Equal-Weight Maintains
2018-10-26 Raymond James Strong Buy Strong Buy Maintains
2018-10-26 Cantor Fitzgerald Overweight Overweight Maintains
2018-10-26 PiperJaffray Overweight Neutral Downgrade
2018-10-01 Cantor Fitzgerald Overweight Initiate
2018-07-26 Baird Outperform Neutral Downgrade
2018-07-26 Morgan Stanley Equal-Weight Equal-Weight Maintains
2018-06-28 Raymond James Strong Buy Initiate
2018-06-19 Baird Outperform Outperform Maintains
2018-05-02 Barclays Overweight Overweight Maintains
2018-05-02 Morgan Stanley Equal-Weight Equal-Weight Maintains
2018-04-19 Longbow Research Neutral Buy Upgrade
2018-03-06 Barclays Overweight Overweight Maintains
2018-02-08 BMO Capital Outperform Market Perform Maintains
2018-02-08 Benchmark Hold Buy Upgrade
2018-02-07 Leerink Swann Market Perform Market Perform Maintains
2018-02-07 Bank of America Neutral Neutral Maintains
2018-02-07 Morgan Stanley Equal-Weight Equal-Weight Maintains
2018-01-30 Citigroup Neutral Buy Upgrade
2018-01-26 Jefferies Hold Buy Upgrade
2018-01-16 Wells Fargo Market Perform Outperform Upgrade
2017-12-20 Credit Suisse Outperform Neutral Downgrade
2017-11-30 Maxim Group Hold Buy Upgrade
2017-11-13 Argus Buy Hold Downgrade
2017-10-30 Benchmark Buy Hold Downgrade
2017-10-27 BMO Capital Outperform Maintains
2017-10-19 Leerink Swann Market Perform Maintains
2017-10-06 Morgan Stanley Equal-Weight Maintains
2017-10-05 Oppenheimer Perform Initiate
2017-10-05 Leerink Swann Market Perform Maintains
2017-10-04 Bank of America Neutral Maintains
2017-09-15 RBC Capital Outperform Initiate
2017-08-31 Argus Hold Buy Upgrade
2017-08-29 Credit Suisse Outperform Maintains
2017-07-26 Redburn Buy Initiate
2017-06-23 Deutsche Bank Buy Initiate
2017-03-09 UBS Buy Neutral Downgrade
2017-02-08 Citigroup Buy Neutral Downgrade
2016-12-01 Summit Redstone Partners Hold Initiate
2016-11-14 Stifel Nicolaus Buy Initiate
2016-11-08 Mizuho Buy Initiate
2016-11-02 BMO Capital Market Perform Outperform Upgrade
2016-10-05 Jefferies Buy Maintains
2016-10-03 RBC Capital Outperform Maintains
2016-09-27 Leerink Swann Outperform Market Perform Downgrade
2016-09-22 Berenberg Buy Initiate
2016-09-14 Credit Suisse Outperform Maintains
2016-09-12 Berenberg Buy Initiate
2016-09-06 Jefferies Hold Buy Upgrade
2016-08-31 Jefferies Hold Maintains
2016-07-29 Argus Buy Hold Downgrade
2016-07-26 Needham Buy Hold Downgrade
2016-06-01 Gabelli & Co. Buy Initiate
2016-05-26 Morgan Stanley Equal-Weight Maintains
2016-04-05 BMO Capital Market Perform Initiate
2016-03-23 Credit Suisse Outperform Maintains
2016-03-15 Jefferies Hold Maintains
2016-02-25 Citigroup Buy Initiate
2016-02-11 Oppenheimer Outperform Initiate
2016-02-05 Leerink Swann Outperform Initiate
2016-02-03 Credit Suisse Outperform Maintains
2016-02-03 Oppenheimer Outperform Maintains
2016-02-03 Standpoint Research Buy Initiate
2016-01-20 Credit Suisse Outperform Initiate
2016-01-15 Bank of America Underperform Neutral Upgrade
2015-12-18 Atlantic Equities Neutral Initiate
2015-11-05 PiperJaffray Neutral Overweight Upgrade
2015-10-20 Oppenheimer Outperform Maintains
2015-10-15 Jefferies Hold Maintains
2015-10-02 Morgan Stanley Overweight Equal-Weight Downgrade
2015-09-09 Jefferies Hold Initiate
2015-07-29 Deutsche Bank Buy Maintains
2015-07-29 Barclays Overweight Maintains
2015-07-06 Bank of America Underperform Maintains
2015-06-05 Longbow Research Buy Neutral Downgrade
2015-03-27 Raymond James Strong Buy Outperform Downgrade
2015-02-06 Credit Suisse Outperform Neutral Downgrade
2015-02-05 Citigroup Buy Maintains
2015-02-04 UBS Buy Maintains
2015-01-06 Barclays Overweight Initiate
2014-12-23 Deutsche Bank Buy Maintains
2014-12-22 Bank of America Buy Underperform Downgrade
2014-12-09 Morgan Stanley Equal-Weight Maintains
2014-12-05 JP Morgan Overweight Maintains
2014-11-10 Nomura Buy Maintains
2014-10-31 Edward Jones Hold Initiate
2014-10-29 Nomura Buy Maintains
2014-10-15 Raymond James Outperform Strong Buy Upgrade
2014-10-13 FBR Capital Outperform Maintains
2014-09-19 Citigroup Buy Maintains
2014-09-10 Baird Outperform Neutral Downgrade
2014-08-08 Raymond James Outperform Maintains
2014-07-24 JP Morgan Overweight Maintains
2014-07-18 Nomura Buy Maintains
2014-06-10 Topeka Buy Maintains
2014-06-10 Raymond James Outperform Maintains
2014-05-09 Raymond James Outperform Maintains
2014-04-23 Nomura Buy Maintains
2014-04-23 Deutsche Bank Buy Maintains
2014-04-22 Jefferies Hold Maintains
2014-04-15 Longbow Research Buy Maintains
2014-04-14 Wells Fargo Buy Maintains
2014-04-10 Nomura Buy Maintains
2014-03-27 Morgan Stanley Equal-Weight Initiate
2014-02-05 Stifel Nicolaus Buy Maintains
2014-02-04 Nomura Buy Maintains
2014-02-04 Baird Neutral Outperform Upgrade
2014-01-28 Deutsche Bank Buy Maintains
2014-01-08 Nomura Buy Initiate
2014-01-06 UBS Buy Maintains
2013-12-18 JP Morgan Overweight Maintains
2013-11-26 Jefferies Hold Maintains
2013-11-25 Deutsche Bank Buy Maintains
2013-11-20 Citigroup Buy Maintains
2013-11-11 Raymond James Strong Buy Outperform Downgrade
2013-10-30 BMO Capital Outperform Maintains
2013-10-11 Longbow Research Neutral Buy Upgrade
2013-07-26 Atlantic Equities Neutral Overweight Upgrade
2013-07-26 Baird Outperform Neutral Downgrade
2013-06-26 Sterne Agee Buy Maintains
2013-06-13 Argus Hold Buy Upgrade
2013-06-11 Sterne Agee Buy Maintains
2013-05-23 Topeka Buy Initiate
2013-05-06 Baird Neutral Outperform Upgrade
2013-04-23 PiperJaffray Overweight Maintains
2013-04-22 Morgan Stanley Overweight Maintains
2013-04-22 Maxim Group Buy Maintains
2013-04-16 Deutsche Bank Buy Maintains
2013-04-15 Leerink Swann Outperform Maintains
2013-04-12 UBS Buy Maintains
2013-04-08 Blaylock Robert Van Buy Initiate
2013-04-04 Credit Suisse Outperform Maintains
2013-03-18 Citigroup Buy Maintains
2013-03-14 Oppenheimer Outperform Maintains
2013-03-05 PiperJaffray Overweight Maintains
2013-02-19 Credit Suisse Neutral Outperform Upgrade
2013-02-05 Atlantic Equities Overweight Neutral Downgrade
2013-02-05 Stifel Nicolaus Buy Maintains
2013-02-05 UBS Buy Maintains
2013-02-05 Jefferies Hold Maintains
2013-01-30 Deutsche Bank Buy Maintains
2013-01-30 UBS Buy Maintains
2013-01-03 Baird Outperform Initiate
2012-12-27 Benchmark Buy Maintains
2012-12-18 UBS Buy Maintains
2012-12-18 Morgan Stanley Overweight Maintains
2012-12-17 Sterne Agee Neutral Buy Upgrade
2012-12-14 PiperJaffray Overweight Maintains
2012-12-04 Barclays Overweight Maintains
2012-11-13 Deutsche Bank Buy Maintains
2012-11-13 Stifel Nicolaus Buy Maintains
2012-10-24 Credit Suisse Neutral Maintains
2012-10-24 BMO Capital Outperform Maintains
2012-10-24 Jefferies Hold Maintains
2012-10-15 Barclays Overweight Maintains
2012-10-08 PiperJaffray Overweight Maintains
2012-10-03 UBS Buy Maintains
2012-10-03 Sterne Agee Underperform Maintains
2012-10-01 Bernstein Market Perform Outperform Upgrade
2012-09-27 Bank of America Buy Maintains
2012-09-19 Deutsche Bank Buy Maintains
2012-09-17 JP Morgan Overweight Maintains
2012-08-30 UBS Buy Maintains
2012-08-28 Jefferies Hold Maintains
2012-08-28 Stifel Nicolaus Buy Maintains
2012-08-15 Deutsche Bank Buy Maintains
2012-08-09 Benchmark Buy Maintains
2012-08-02 Barclays Equal-Weight Overweight Upgrade
2012-08-02 Deutsche Bank Buy Maintains
2012-07-27 Stifel Nicolaus Buy Maintains
2012-07-27 Jefferies Hold Maintains
2012-02-10 Morgan Stanley Overweight Initiate
2024-09-04 RBC Capital Sector Perform Sector Perform Maintains
2025-02-12 Piper Sandler Overweight Overweight Maintains
2025-02-12 Morgan Stanley Overweight Overweight Maintains
2025-02-12 Needham Hold Hold Reiterate
2025-03-27 JP Morgan Overweight Overweight Maintains
2024-09-11 Piper Sandler Overweight Overweight Maintains
2024-11-18 RBC Capital Sector Perform Sector Perform Maintains
2024-10-04 RBC Capital Sector Perform Sector Perform Maintains
2025-03-05 Wells Fargo Overweight Overweight Maintains
2025-03-05 B of A Securities Buy Buy Maintains
2024-10-09 JP Morgan Overweight Overweight Maintains
2025-01-29 JP Morgan Overweight Overweight Maintains
2024-12-10 B of A Securities Buy Reiterate
2024-12-10 Oppenheimer Outperform Outperform Maintains
2025-03-11 Morgan Stanley Overweight Overweight Maintains
2025-02-18 Deutsche Bank Hold Buy Upgrade
2024-12-11 RBC Capital Sector Perform Sector Perform Reiterate
2024-12-11 Cantor Fitzgerald Neutral Neutral Reiterate
2025-07-25 Needham Hold Buy Upgrade
2025-04-25 Morgan Stanley Overweight Overweight Maintains
2025-04-25 Oppenheimer Outperform Outperform Maintains
2025-04-25 Needham Hold Hold Reiterate
2025-08-08 UBS Neutral Neutral Maintains
2025-08-08 RBC Capital Sector Perform Sector Perform Maintains
2025-08-08 Truist Securities Hold Buy Upgrade
2025-05-21 Needham Hold Hold Reiterate
Revenue Estimates
No data available.
Earnings Estimates

The forecasted annual earnings of Gilead Sciences, Inc. in 2032-12-31 is 10.10 per share.

One part of an analyst’s rating is a profit (i.e., earnings) estimate for the current quarter and/or future quarters. The measurement given is earnings per share (EPS). EPS is a metric that indicates how much a company earned as represented by one share of its stock over a specific period (typically three months).

Earnings per Share Calculation

To understand the earnings per share calculation, you must understand net income. Net income is the amount of money a company has left over after deducting appropriate expenses and taxes from its revenues).

The formula for earnings per share is net income divided by the total number of outstanding shares (i.e., available for purchase). For example:

Company A has a net income of $100 million and forty million outstanding shares. The EPS calculation is as follows:

100,000,000/40,000,000 = $2.50 per share

How to use Earnings Per Share in Stock Analysis

Earnings per share is an essential metric for you to consider when deciding to buy a stock. After all, a company with high earnings per share is productive and generates revenue in excess of its operating costs.

However, it’s not the only metric you should use. Metrics like price-to-earnings and debt-to-equity add additional perspective about a company’s health.

You should also be sure to compare a company’s EPS with a company in its sector. However, when you do, be aware that EPS is different and more important than net profit by itself. You may see a company that has a rising net profit. But if its outstanding shares are also rising, then its EPS might be flat or even edging lower.

Update Frequency: Quarterly

Date EPS Average (Quarterly) Number of Analysts (Quarterly) EPS Average (Annual) Number of Analysts (Annually)
2025-09-30 2.07 5 -- --
2025-12-31 2.16 5 7.26 32
2026-03-31 2.10 3 -- --
2026-06-30 2.23 3 -- --
2026-09-30 2.31 3 -- --
2026-12-31 2.25 3 7.68 28
2027-12-31 -- -- 8.00 17
2028-12-31 -- -- 8.44 16
2029-12-31 -- -- 8.94 12
2030-12-31 -- -- 9.14 11
2031-12-31 -- -- 9.67 10
2032-12-31 -- -- 10.10 8
EBITDA Estimates
No data available.
EBIT Estimates
No data available.
Other Listings
PE:GILD
IT:1GILD €97.24
CH:000935700
MX:GILD
US:GILD $115.05
DE:GIS €96.56
AT:GILD
GB:GISD
GB:0QYQ $114.90
CL:GILD
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista